News at CenExel

Placebo and Nocebo Response Mitigation

Empirical Strategies to Mitigate Placebo and Nocebo Effects CenExel sites are committed to enhancing understanding of the causes and implications of the placebo and nocebo effects within central nervous system and internal medicine clinical trials and developing...

CenExel FCR Wins Best of the Best

Tampa, Florida, July 26, 2023 /GlobeNewswire/ — CenExel FCR has been named the 2023 Tampa Bay Times People's Choice, Best of the Best in Clinical Research. This remarkable achievement showcases CenExel FCR's unwavering dedication to advancing medical knowledge and...

CenExel Acquires ForCare Clinical Research

Salt Lake City, August 4, 2021 /GlobeNewswire/ — CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years...